News: $NOVN First Patient Enrolled and Dosed in Novan's SB206 Phase 3 Molluscum Program
Phase 3 pivotal program commences and underway Investigative sites now activated and enrollment activities actioned Anticipated patient demand managed with a highly disciplined approach to trial execution Top line results targeted to be no later than early in the first quarter o...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.